Figure 4. NEFL expression is associated with good outcome and favorable neuroblastoma stages.
(A–C) Kaplan Meier analysis using published array data (Oncogenomics lab web tool). (D) Kaplan Meier analysis using combined array data from the three independent sets. (E) Meta-analysis of Hazard ratios from the Cox regression analysis of each dataset. (F) Changes in expression for NEFL in ganglioneuroblastoma (GNB) and ganglioneuroma (GN) and (G) in favorable stage using published array data (GEO database).